Total Payments
$979.06
2024 Payments
$74.85
Companies
14
Transactions
49
Medicare Patients
3,988
Medicare Billing
$375,307
Payment Breakdown by Category
Food & Beverage$775.48 (79.2%)
Education$203.58 (20.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $775.48 | 45 | 79.2% |
| Education | $203.58 | 4 | 20.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $491.80 | 23 | $0 (2024) |
| AbbVie Inc. | $92.07 | 5 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $67.65 | 4 | $0 (2022) |
| Allergan Inc. | $66.80 | 2 | $0 (2018) |
| Boston Scientific Corporation | $59.97 | 4 | $0 (2023) |
| PFIZER INC. | $48.81 | 3 | $0 (2019) |
| Laborie Medical Technologies Corp. | $23.65 | 1 | $0 (2024) |
| UROVANT SCIENCES INC | $21.33 | 1 | $0 (2022) |
| Antares Pharma, Inc. | $20.26 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $20.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.85 | 4 | Astellas Pharma US Inc ($33.54) |
| 2023 | $241.77 | 11 | Astellas Pharma US Inc ($187.04) |
| 2022 | $217.68 | 13 | ABBVIE INC. ($72.08) |
| 2021 | $14.74 | 1 | Myriad Genetic Laboratories, Inc. ($14.74) |
| 2020 | $66.16 | 4 | Astellas Pharma US Inc ($30.32) |
| 2019 | $68.39 | 4 | Janssen Biotech, Inc. ($20.05) |
| 2018 | $125.10 | 6 | Allergan Inc. ($66.80) |
| 2017 | $170.37 | 6 | Astellas Pharma US Inc ($151.19) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: rezum_URO | ||||||
| 07/12/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/15/2022 | Myriad Genetic Laboratories, Inc. | BRAC CDx (Device) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 12/14/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/12/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: ONCOLOGY | ||||||
| 02/18/2020 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: PROSTATE HEALTH | ||||||
| 01/22/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Rheumatoid Arthritis | ||||||
| 01/15/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: UROLOGY | ||||||
| 12/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 07/22/2019 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.20 | General |
| 02/26/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 09/25/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.85 | General |
| 05/09/2018 | Allergan Inc. | BOTOX (Biological) | Education | In-kind items and services | $35.95 | General |
| 03/28/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 03/23/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: UROLOGY | ||||||
| 02/08/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 10/03/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Oncology | ||||||
| 07/12/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Urology | ||||||
| 05/11/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), TESTOPEL | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 05/03/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $88.00 | General |
| 05/03/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,101 | 1,793 | $297,835 | $106,996 |
| 2022 | 15 | 973 | 1,504 | $257,152 | $98,202 |
| 2021 | 14 | 859 | 1,186 | $187,231 | $82,991 |
| 2020 | 21 | 1,055 | 1,469 | $212,076 | $87,118 |
Total Patients
3,988
Total Services
5,952
Medicare Billing
$375,307
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 444 | $95,904 | $37,292 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 163 | $47,759 | $20,224 | 42.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 102 | $33,150 | $11,104 | 33.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 89 | 235 | $21,385 | $9,637 | 45.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 41 | 45 | $19,125 | $8,220 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $21,580 | $8,084 | 37.5% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 36 | 85 | $12,325 | $2,821 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 47 | $7,003 | $2,296 | 32.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 47 | 58 | $12,470 | $2,062 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,600 | $1,889 | 28.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 151 | 221 | $8,840 | $1,607 | 18.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 34 | $3,060 | $661.38 | 21.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 154 | 237 | $2,370 | $511.12 | 21.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 31 | 36 | $5,760 | $321.59 | 5.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 14 | $504.00 | $265.86 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 383 | $82,728 | $32,173 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 98 | 156 | $45,708 | $20,086 | 43.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 12 | 84 | $27,300 | $9,596 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $21,580 | $7,765 | 36.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 162 | $14,742 | $6,949 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 111 | $16,539 | $6,442 | 38.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 31 | 33 | $14,025 | $6,089 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,260 | $2,530 | 34.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 29 | 40 | $8,600 | $1,625 | 18.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 11 | 11 | $2,365 | $1,245 | 52.6% |
About Dr. John Chesson, MD
Dr. John Chesson, MD is a Urology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518905728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Chesson, MD has received a total of $979.06 in payments from pharmaceutical and medical device companies, with $74.85 received in 2024. These payments were reported across 49 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($775.48).
As a Medicare-enrolled provider, Chesson has provided services to 3,988 Medicare beneficiaries, totaling 5,952 services with total Medicare billing of $375,307. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Winchester, VA
- Active Since 06/02/2006
- Last Updated 04/18/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518905728
Products in Payments
- Myrbetriq (Drug) $233.45
- LUPRON DEPOT (Drug) $92.07
- BOTOX (Biological) $66.80
- XTANDI (Drug) $65.92
- Prolaris (Device) $51.04
- GEMTESA (Drug) $39.96
- TOVIAZ (Drug) $34.18
- Xtandi (Drug) $28.40
- rezum Generator (Device) $28.28
- MYRBETRIQ (Drug) $25.66
- Urgent PC Neuromodulation System (Device) $23.65
- OTREXUP (Drug) $20.26
- Erleada (Drug) $20.05
- XIAFLEX (Biological) $19.18
- Tiopronin (Drug) $17.66
- BRAC CDx (Device) $16.61
- Rezum Generator (Device) $16.11
- REZUM (Device) $15.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Winchester
Kevin Geib, Md, MD
Urology — Payments: $18,587
Urology $18,587
Dr. Megan Bing, Md, MD
Urology — Payments: $9,721
Urology $9,721
Dr. Freddie Terrell, Md, MD
Urology — Payments: $4,379
Urology $4,379
Dr. Michael Hoffman, Md, MD
Urology — Payments: $2,172
Urology $2,172
Dr. Mark Levinson, M.d, M.D
Urology — Payments: $1,981
Urology $1,981
Michael Strickland, Do, DO
Urology — Payments: $1,723
Urology $1,723